Your browser doesn't support javascript.
loading
Successes and Opportunities during the Pandemic: Reflections and Revelations from a Vaccine Development Perspective.
Heaton, Penny M; Palaniappan, Kavitha; Stona, Anne-Claire; Vogel, Silke; Lim, John C W.
Afiliação
  • Heaton PM; The Janssen Pharmaceutical Companies of Johnson & Johnson, Singapore, Singapore.
  • Palaniappan K; Duke-NUS Medical School, Centre of Regulatory Excellence, Singapore, Singapore.
  • Stona AC; Duke-NUS Medical School, Centre of Regulatory Excellence, Singapore, Singapore.
  • Vogel S; Duke-NUS Medical School, Centre of Regulatory Excellence, Singapore, Singapore.
  • Lim JCW; Duke-NUS Medical School, Centre of Regulatory Excellence, Singapore, Singapore.
Clin Pharmacol Ther ; 114(3): 504-506, 2023 09.
Article em En | MEDLINE | ID: mdl-36965070
ABSTRACT
The Centre of Regulatory Excellence (CoRE) launched an annual lecture series in 2021 in Singapore to honor the memory of the late Professor Sir Alasdair Breckenridge, CoRE's founding Chair, and foster dialogue on global biomedical and regulatory perspectives, challenges, and advances. The 2022 Sir Alasdair Breckenridge Lecture "Success and Opportunities in the Pandemic" was delivered by Dr Penny M Heaton, former CEO of the Bill & Melinda Gates Foundation Research Institute and current Global Therapeutics Lead for Vaccines at Johnson & Johnson. Dr Heaton highlighted key lessons on the importance of trust, collaboration, and transparency in the context of health care and vaccine production.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas / Pandemias Limite: Humans País como assunto: Asia Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas / Pandemias Limite: Humans País como assunto: Asia Idioma: En Ano de publicação: 2023 Tipo de documento: Article